[4th March 2026]

We’re very pleased welcome Professor Cristian Ilie as one of the newest members of our Medical Advisory Panel.

Our Medical Advisory Panel brings together experienced clinicians from across the UK with a shared focus on Pelvic Radiation Disease (PRD). Their expertise helps ensure that the guidance and information we provide is accurate, evidence-based, and aligned with the best clinical practice.

Professor Ilie is a Consultant Urological Surgeon and robotic specialist, holding clinical roles at both Norfolk and Norwich University Hospital (NNUH) and The Queen Elizabeth Hospital Kings Lynn (QEHKL), where he serves as Clinical Lead. Specialising in urological oncology and the management of complex pelvic radiation-induced complications, he is a Visiting Professor at Anglia Ruskin University and a graduate of both the Harvard Surgical Leadership Programme and the University of Cambridge Executive MBA.

Professor Ilie is deeply committed to improving the quality of life for patients living with the late effects of pelvic radiotherapy. As a robotic surgeon, he focuses on precision interventions and has pioneered research into the cystoscopic application of PuraStat® for treating radiation-induced haemorrhagic cystitis — a major advancement in managing chronic bladder bleeding following radiotherapy.

In addition to his clinical practice, he is the Editor-in-Chief of the Atena Journal of Urology and an expert adviser for the EU Horizon 2020 CANCERLESS project. By bridging the gap between robotic surgical innovation and patient-centred care, he helps ensure that individuals affected by Pelvic Radiation Disease have access to the most advanced evidence-based treatments. He is a Fellow of the Royal College of Surgeons of Edinburgh and the European Board of Urology.

We’re delighted to welcome Professor Ilie to the Panel. His clinical leadership and pioneering work in radiation-induced urological complications will play an important role in shaping our ongoing efforts to promote best practice in the management of Pelvic Radiation Disease.

Learn more about our Medical Advisory Panel.